Navigation Links
CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
Date:7/19/2011

MATTHEWS, N.C., July 19, 2011 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the Commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 20, 2011. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school for a number of years.

(Logo:  http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

"I am honored to have been asked to deliver the Commencement address this year," said Michael J. Collins. "UT has one of the strongest chemistry and biochemistry programs in the country with very talented and promising students. It was wonderful to have the opportunity to share my experiences with them and I appreciate them sharing their special day with me."

Collins told the audience about his time at the University of Texas at Austin and how it helped shape his life. He drew comparisons between the economic outlook when he graduated and the world that today's graduates will be facing, predicting that the same economic trends that brought the prosperity of the past twenty-five years will again bring rapid economic growth in the next five years.

"Technology will continue to transform the world we live in and most of the transformational innovations will be chemistry and biochemistry based," said Collins. "All of you have chosen a great field of endeavor and your futures should be very bright."

Collins encouraged his audience to be passionate about their dreams, to explore and take risks, and to not be intimidated by people who tell them that something is impossible. Collins said, "Have fun doing the impossible!"

A prepared text of Dr. Collins' Commencement address is available on CEM's website at www.cem.com.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
2. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
3. RainDance Technologies Appoints Olex Vice President, System Development
4. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
5. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
6. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
9. UltraShape Appoints Assaf Eyal as President & CEO
10. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
11. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):